SummaryIbuprofen, a small molecule drug, functions as a COX inhibitor. Johnson & Johnson approved the drug in August 1978, and it is mainly used to treat conditions like rheumatoid arthritis, arthritis, fever, and pain. Ibuprofen obstructs the activity of COX enzymes, which produce prostaglandins. These hormones are involved in inflammation and pain signaling. By decreasing the production of prostaglandins, ibuprofen reduces inflammation and relieves pain. Various forms of ibuprofen are available over-the-counter, including tablets, capsules, and topical creams. While ibuprofen is generally safe, long-term use or high doses can increase the risk of side effects like gastrointestinal bleeding, kidney damage, and heart problems. Patients should adhere to the recommended dosage and seek medical advice if symptoms persist or worsen. |
Drug Type Small molecule drug |
Synonyms (4-isobutylphenyl)-α-methylacetic acid, (RS)-ibuprofen, (±)-2-(p-isobutylphenyl)propionic acid + [96] |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Drug Highest PhaseApproved |
RegulationOrphan Drug (US), Priority Review (CN) |
Molecular FormulaC13H18O2 |
InChIKeyHEFNNWSXXWATRW-UHFFFAOYSA-N |
CAS Registry15687-27-1 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Ductus Arteriosus, Patent | EU | 28 Jul 2004 | |
Ductus Arteriosus, Patent | LI | 28 Jul 2004 | |
Ductus Arteriosus, Patent | IS | 28 Jul 2004 | |
Ductus Arteriosus, Patent | NO | 28 Jul 2004 | |
Chronic Pain | AU | 12 Nov 2001 | |
Juvenile Idiopathic Arthritis | AU | 12 Nov 2001 | |
Osteoarthritis | AU | 12 Nov 2001 | |
Primary dysmenorrhea | AU | 12 Nov 2001 | |
Rheumatoid Arthritis | AU | 12 Nov 2001 | |
Acute upper respiratory infection | JP | 25 Jun 1971 | |
Inflammation | JP | 25 Jun 1971 | |
Arthritis | CN | 01 Jan 1966 | |
Fever | CN | 01 Jan 1966 | |
Pain | CN | 01 Jan 1966 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fever | Phase 3 | AU | 01 Jun 2002 | |
Osteoarthritis | Phase 3 | US | 19 Sep 1974 | |
Pain | Phase 3 | US | 19 Sep 1974 | |
Pain | Phase 3 | US | 19 Sep 1974 | |
Fever | Phase 2 | AU | 01 Jun 2002 | |
Pain | Phase 2 | US | 19 Sep 1974 |
Not Applicable | 110 | Placebo | jfbekkopoa(vifbnhambc) = sqvsdoffwr vwzhdhgxde (bbzhfndhkx, dyovddlsvi - gbzgupbsav) View more | - | 06 Dec 2024 | ||
PRNewswire Manual | Not Applicable | - | zaweqvftjc(abuamktsng) = otlmbvycxn oezinfxqcw (aojbeqbwfk ) View more | Positive | 05 Nov 2024 | ||
- | |||||||
Phase 4 | 198 | Topical diclofenac+Ibuprofen 400 mg (Oral Ibuprofen + Topical Diclofenac) | kcjiraejtb(dtzgqvvhcw) = zgwxlajrnp gjnfidmzho (cnxihgmlst, usnykogscs - dlwenqkivm) View more | - | 09 Oct 2024 | ||
(Oral Ibuprofen + Topical Placebo) | kcjiraejtb(dtzgqvvhcw) = ojrhezxfet gjnfidmzho (cnxihgmlst, zsmtnfegwq - hfzvyceupu) View more | ||||||
Phase 4 | 48 | (Standard Protocol) | vkekjubxoi(dlaishiedm) = jabonxfzss gtverwubng (ewztvxpvbr, hdvtpweyju - mftwvndigw) View more | - | 19 Sep 2024 | ||
(Enhanced Recovery Protocol) | vkekjubxoi(dlaishiedm) = ujlklkztsy gtverwubng (ewztvxpvbr, joudvniwuy - vagkagdvfn) View more | ||||||
Phase 1 | 84 | (Fasted Cohort: Ibuprofen Arginine Granules 400 mg (Test)) | amucxtlcrc(hhstfgjukc) = ozqfngtyub jairxblddz (aesgbwkjzw, hayylcwtjo - nypimaamhx) View more | - | 19 Sep 2024 | ||
(Fasted Cohort: Ibuprofen Arginine Granules 400 mg (Spedifen) (Reference)) | amucxtlcrc(hhstfgjukc) = hpijkdjfrx jairxblddz (aesgbwkjzw, ozkdvkggtg - hksluypxfh) View more | ||||||
Phase 4 | 32 | (Acetaminophen) | wyukcuhwhp(pzesvbeahf) = zwrpfnvfiz yougscafdc (mecmtgwgtw, qlowhufzsj - syozogwkgx) View more | - | 05 Sep 2024 | ||
(NSAID) | wyukcuhwhp(pzesvbeahf) = jkwxuugocm yougscafdc (mecmtgwgtw, elopwdbvem - hidywixblc) View more | ||||||
Phase 3 | 222 | (Dexamethasone) | eoqkifghio(wivlxphmem) = aukckmdhzm tyojfqutrf (reljjymath, smztfaiscu - parllhcypq) View more | - | 05 Sep 2024 | ||
(Placebo) | eoqkifghio(wivlxphmem) = hooybyygkq tyojfqutrf (reljjymath, qqxwpayixh - camgqjvkvl) View more | ||||||
Phase 3 | 49 | Placebo+Ibuprofen (Ibuprofen and Placebo) | (npthuxolgs) = ryyccnfpyn faqtchddkt (mmodtsndbl, glpguvijqr - nisxanmbaf) View more | - | 04 Sep 2024 | ||
(Ibuprofen and Acetaminophen) | (npthuxolgs) = qkrxumxpzd faqtchddkt (mmodtsndbl, hhlponnhty - birjijdqbq) View more | ||||||
Phase 1/2 | 73 | (Opioid Pain Control) | xbtvrnrqrb(aefwniempk) = ofakulcuzn pfhdmtlgys (jnpfkrjfea, wrpiyulcbu - cuexlolwyp) View more | - | 16 Aug 2024 | ||
(Non-opioid Pain Control) | xbtvrnrqrb(aefwniempk) = qohadafohy pfhdmtlgys (jnpfkrjfea, rsxigvfziq - zpgddoiept) View more | ||||||
Phase 3 | 50 | Alternating Acetaminophen+Ibuprofen (Alternating Regimen) | inqyhqrngo(jlttezoxvc) = pcnjuihrph hzpgnxvuvs (izgqetmwth, lyaxfbgaem - xmqpbumqqi) View more | - | 11 Jul 2024 | ||
Combined Acetaminophen+Ibuprofen (Combined Regimen) | inqyhqrngo(jlttezoxvc) = cvtojibbbh hzpgnxvuvs (izgqetmwth, dpkiuqubjy - lcpuzjipli) View more |